Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ADMS - Adamas Pharmaceuticals Inc

Close
8.22
0.060   0.730%

Share volume: 0
Last Updated: Tue 23 Nov 2021 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$8.16
0.06
0.74%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 37%
Dept financing 23%
Liquidity 48%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$8.22
P/E Ratio 
0.00
DAY RANGE
$8.22 - $8.22
EPS 
-$1.62
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
45.787 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO: Neil McFarlane
Region: US
Website: www.adamaspharma.com
Employees: 138
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.

Recent news